MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 15 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,965,000 | -24.2% | 3,500,000 | 0.0% | 1.77% | -25.8% |
| Q1 2016 | $5,233,000 | +4.1% | 3,500,000 | 0.0% | 2.38% | +19.4% |
| Q4 2015 | $5,027,000 | -4.4% | 3,500,000 | 0.0% | 2.00% | +2.9% |
| Q3 2015 | $5,259,000 | -28.2% | 3,500,000 | 0.0% | 1.94% | -12.8% |
| Q2 2015 | $7,328,000 | -34.3% | 3,500,000 | -36.4% | 2.22% | -62.5% |
| Q1 2015 | $11,154,000 | +9.1% | 5,500,000 | 0.0% | 5.93% | +5.8% |
| Q4 2014 | $10,225,000 | +20.4% | 5,500,000 | 0.0% | 5.61% | +27.4% |
| Q3 2014 | $8,496,000 | +13.4% | 5,500,000 | 0.0% | 4.40% | +26.9% |
| Q2 2014 | $7,490,000 | – | 5,500,000 | – | 3.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,762,000 | $22,928,000 | 0.34% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,998,000 | $8,555,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,331,000 | $1,138,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 2,876,000 | $2,459,000 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 3,300,000 | $2,838,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 3,320,000 | $2,839,000 | 0.00% |
| UBS Group AG | 1,000 | $1,000 | 0.00% |
| Jefferies Group LLC | 10,000 | $8,000 | 0.00% |
| JPMORGAN CHASE & CO | 2,015,000 | $1,730,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,000 | $7,000 | 0.00% |